| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |